Scottish Investment Bank invests in Strathclyde spinout Mironid's $5.7m series A to support its therapy for degenerative kidney disease, major inflammatory disease and cancer.

The UCL Technology Fund invests in gene therapy company Freeline, which hopes to treat blood diseases such as haemophilia B.

Delft University of Technology-backed venture fund Icos Capital supplies capital to solar technology developer Exasun.

Danone Manifesto Ventures is set to make its first investment, entering talks with food brand Michel et Augustin, reportedly to acquire a stake of up to 40%.

Imperial Innovations has contributed to a series A round for small-molecule oncology treatment developer Storm Therapeutics, a Cambridge spinout.

EMBL Ventures backs Allecra Therapeutics' series B round that will support a phase 2 clinical trial for a therapy aimed at drug-resistant bacteria.

E-commerce firm and existing investor Vente-Privee has returned to take part in another funding round for online flight booking startup MisterFly.

The industrial product maker will launch the Next47 unit in October and invest $1.1bn in innovative technology developers over the next five years.

Pfizer and Merck's corporate venturing vehicles have contributed to small-molecule oncology treatment developer Storm Therapeutics' series A round.

Cambridge University spinout and Cambridge Enterprise Fund portfolio company Cambridge CMOS Sensors has been acquired for an undisclosed amount by Ams.